These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32052931)

  • 21. Gene expression profiling of skeletal muscle after volumetric muscle loss.
    Nuutila K; Sakthivel D; Kruse C; Tran P; Giatsidis G; Sinha I
    Wound Repair Regen; 2017 May; 25(3):408-413. PubMed ID: 28494512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decellularized extracellular matrix gelloids support mesenchymal stem cell growth and function in vitro.
    Talovic M; Patel K; Schwartz M; Madsen J; Garg K
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1830-1842. PubMed ID: 31306568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regenerative Repair of Volumetric Muscle Loss Injury is Sensitive to Age.
    Kim JT; Kasukonis B; Dunlap G; Perry R; Washington T; Wolchok JC
    Tissue Eng Part A; 2020 Jan; 26(1-2):3-14. PubMed ID: 31064280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perfusable adipose decellularized extracellular matrix biological scaffold co-recellularized with adipose-derived stem cells and L6 promotes functional skeletal muscle regeneration following volumetric muscle loss.
    Liang W; Han M; Li G; Dang W; Wu H; Meng X; Zhen Y; Lin W; Ao R; Hu X; An Y
    Biomaterials; 2024 Jun; 307():122529. PubMed ID: 38489911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury.
    Corona BT; Ward CL; Baker HB; Walters TJ; Christ GJ
    Tissue Eng Part A; 2014 Feb; 20(3-4):705-15. PubMed ID: 24066899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A porous collagen-GAG scaffold promotes muscle regeneration following volumetric muscle loss injury.
    Panayi AC; Smit L; Hays N; Udeh K; Endo Y; Li B; Sakthivel D; Tamayol A; Neppl RL; Orgill DP; Nuutila K; Sinha I
    Wound Repair Regen; 2020 Jan; 28(1):61-74. PubMed ID: 31603580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asynchronous inflammation and myogenic cell migration limit muscle tissue regeneration mediated by a cellular scaffolds.
    Garg K; Ward CL; Corona BT
    Inflamm Cell Signal; 2014; 1(4):. PubMed ID: 26949720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photoreactive Hydrogel Stiffness Influences Volumetric Muscle Loss Repair.
    Basurto IM; Passipieri JA; Gardner GM; Smith KK; Amacher AR; Hansrisuk AI; Christ GJ; Caliari SR
    Tissue Eng Part A; 2022 Apr; 28(7-8):312-329. PubMed ID: 34409861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A PEGylated platelet free plasma hydrogel based composite scaffold enables stable vascularization and targeted cell delivery for volumetric muscle loss.
    Aurora A; Wrice N; Walters TJ; Christy RJ; Natesan S
    Acta Biomater; 2018 Jan; 65():150-162. PubMed ID: 29128541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laminin-111-Enriched Fibrin Hydrogels Enhance Functional Muscle Regeneration Following Trauma.
    Ziemkiewicz N; Hilliard GM; Dunn AJ; Madsen J; Haas G; Au J; Genovese PC; Chauvin HM; West C; Paoli A; Garg K
    Tissue Eng Part A; 2022 Apr; 28(7-8):297-311. PubMed ID: 34409846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of Volumetric Muscle Loss Injury.
    Corona BT; Wenke JC; Ward CL
    Cells Tissues Organs; 2016; 202(3-4):180-188. PubMed ID: 27825160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 inhibition does not alter wound healing outcomes of a volumetric muscle loss injury treated with a biologic scaffold.
    Goldman SM; Valerio MS; Janakiram NB; Dearth CL
    J Tissue Eng Regen Med; 2020 Dec; 14(12):1929-1938. PubMed ID: 33049117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effects of Engineered Skeletal Muscle on Volumetric Muscle Loss in The Tibialis Anterior Of Rat After Three Months
    Nutter GP; VanDusen KW; Florida SE; Syverud BC; Larkin LM
    Regen Eng Transl Med; 2020 Dec; 6(4):365-372. PubMed ID: 33778156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Potential of Combination Therapeutics for More Complete Repair of Volumetric Muscle Loss Injuries: The Role of Exogenous Growth Factors and/or Progenitor Cells in Implantable Skeletal Muscle Tissue Engineering Technologies.
    Passipieri JA; Christ GJ
    Cells Tissues Organs; 2016; 202(3-4):202-213. PubMed ID: 27825153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of skeletal muscle.
    Corona BT; Garg K; Ward CL; McDaniel JS; Walters TJ; Rathbone CR
    Am J Physiol Cell Physiol; 2013 Oct; 305(7):C761-75. PubMed ID: 23885064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells and myoblast differentiation under HGF and IGF-1 stimulation for 3D skeletal muscle tissue engineering.
    Witt R; Weigand A; Boos AM; Cai A; Dippold D; Boccaccini AR; Schubert DW; Hardt M; Lange C; Arkudas A; Horch RE; Beier JP
    BMC Cell Biol; 2017 Feb; 18(1):15. PubMed ID: 28245809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-delivery of a laminin-111 supplemented hyaluronic acid based hydrogel with minced muscle graft in the treatment of volumetric muscle loss injury.
    Goldman SM; Henderson BEP; Walters TJ; Corona BT
    PLoS One; 2018; 13(1):e0191245. PubMed ID: 29329332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A murine model of volumetric muscle loss and a regenerative medicine approach for tissue replacement.
    Sicari BM; Agrawal V; Siu BF; Medberry CJ; Dearth CL; Turner NJ; Badylak SF
    Tissue Eng Part A; 2012 Oct; 18(19-20):1941-8. PubMed ID: 22906411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionalization of hyaluronic acid hydrogels with ECM-derived peptides to control myoblast behavior.
    Silva Garcia JM; Panitch A; Calve S
    Acta Biomater; 2019 Jan; 84():169-179. PubMed ID: 30508655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation of devitalized muscle scaffolds is insufficient for appreciable de novo muscle fiber regeneration after volumetric muscle loss injury.
    Garg K; Ward CL; Rathbone CR; Corona BT
    Cell Tissue Res; 2014 Dec; 358(3):857-73. PubMed ID: 25300647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.